Iambic Therapeutics, Inc. (IAM)
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Iambic Therapeutics Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 47.40M shares outstanding
No company description available.
Leadership
Michael Secora
Chief Corporate Development Officer & CFO
Thomas Miller
Co-Founder, CEO, Secretary & Director
Laurent Gomez
Senior VP & Head of Discovery
Matt Welborn
Senior Vice President of Machine Learning
Employees
--
Country
--
Sector
Technology
Website
--
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Vogelstein R Jacob | Director | Conversion of Derivative | 2.00M | -- | Oct 16, 2026 |
 RASTETTER WILLIAM H | Director | Conversion of Derivative | 76.8K | -- | Oct 16, 2026 |
| RASTETTER WILLIAM H | Director | Conversion of Derivative | 64.0K | -- | Oct 16, 2026 |
| RASTETTER WILLIAM H | Director | Conversion of Derivative | 36.8K | -- | Oct 16, 2026 |
| RASTETTER WILLIAM H | Director | Conversion of Derivative | 15.0K | -- | Oct 16, 2026 |
| RASTETTER WILLIAM H | Director | Conversion of Derivative | 8.3K | -- | Oct 16, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
 Manby Frederick R Chief Technology Officer, Director | 1.9M | 3.9% | FORM 4 |
 Miller Thomas F. Chief Executive Officer, Director | 1.4M | 3.0% | FORM 4 |
 Secora Michael CFO & Chief Corp Dev Ofcr | 279.9K | 0.6% | FORM 4 |
 Josephson Neil Chief Medical Officer | 71.5K | 0.2% | FORM 4 |
 Olson Peter A Chief Scientific Officer | 30.9K | 0.1% | FORM 4 |
Insiders
- Vogelstein R JacobDirector
- RASTETTER WILLIAM HDirector
- Secora MichaelCFO & Chief Corp Dev Ofcr
- Catalio Capital Management, LP10% Owner
- Rachlin Evan LockwoodDirector
- Manby Frederick RChief Technology Officer
- Josephson NeilChief Medical Officer
- Olson Peter AChief Scientific Officer
- EMSTER KURT VONDirector
- Miller Thomas F.Chief Executive Officer
based on 47.40M shares outstanding
30d Avg
1.42M
60d Avg
1.42M
90d Avg
1.42M